[Federal Register Volume 63, Number 251 (Thursday, December 31, 1998)]
[Notices]
[Page 72316]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 98-34586]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Clinical Laboratory Improvement Advisory Committee (CLIAC): 
Meeting

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following committee meeting.

    Name: Clinical Laboratory Improvement Advisory Committee 
(CLIAC).
    Time and Date: 8 a.m.-4:30 p.m., February 3, 1999.
    Place: CDC, Koger Center, Williams Building, Conference Rooms 
1802 and 1805, 2877 Brandywine Road, Atlanta, Georgia 30341.
    Status: Open to the public, limited only by the space available. 
The meeting rooms accommodate approximately 85 people.
    Purpose: This committee is charged with providing scientific and 
technical advice and guidance to the Secretary of Health and Human 
Services, the Assistant Secretary for Health, and the Director, CDC, 
regarding the need for, and the nature of, revisions to the 
standards under which clinical laboratories are regulated; the 
impact of proposed revisions to the standards; and the modification 
of the standards to accommodate technological advances.
    Matters to be discussed: The agenda will include an update on 
CLIA implementation; HCFA validation inspections of accredited 
laboratories; update on research for CLIA Cytology requirements; and 
information on HCFA inspections of cytology laboratories.
    Agenda items are subject to change as priorities dictate.
    For further information contact: John C. Ridderhof, Dr.P.H., 
Division of Laboratory Systems, Public Health Practice Program 
Office, CDC, 4770 Buford Highway, NE., Mailstop G-25, Atlanta, 
Georgia 30341-3724. Telephone 770/488-8076, FAX 770/488-8282.
    The Director, Management Analysis and Services office has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

    Dated: December 23, 1998.
Carolyn J. Russell,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 98-34586 Filed 12-30-98; 8:45 am]
BILLING CODE 4163-18-P